Home

Antik Latin fena halde lancet medication yakın Ayrıca Dikkatli ol

Effect of dronabinol on progression in progressive multiple sclerosis  (CUPID): a randomised, placebo-controlled trial - The Lancet Neurology
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial - The Lancet Neurology

The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1

The Lancet - The Lancet Oncology | Series | Drug safety in oncology Read  the Series: https://hubs.ly/H0bvBYw0 Given the success of The Lancet  Oncology's last series on drug safety in oncology in
The Lancet - The Lancet Oncology | Series | Drug safety in oncology Read the Series: https://hubs.ly/H0bvBYw0 Given the success of The Lancet Oncology's last series on drug safety in oncology in

Racial/ethnic and socioeconomic disparities in the use of newer diabetes  medications in the Look AHEAD study - The Lancet Regional Health – Americas
Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study - The Lancet Regional Health – Americas

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on  immunosuppressive therapies: a Norwegian cohort study - The Lancet  Rheumatology
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study - The Lancet Rheumatology

Antipsychotic drug effective and safe in paranoid older people who usually  aren't treated | UCL News - UCL – University College London
Antipsychotic drug effective and safe in paranoid older people who usually aren't treated | UCL News - UCL – University College London

Antihypertensive medications and risk for incident dementia and Alzheimer's  disease: a meta-analysis of individual participant data from prospective  cohort studies - The Lancet Neurology
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies - The Lancet Neurology

eClinicalMedicine Home Page
eClinicalMedicine Home Page

Lancet, NEJM retract Covid-19 studies that sparked backlash
Lancet, NEJM retract Covid-19 studies that sparked backlash

Maintenance therapy after quadruple induction therapy in HIV-1 infected  individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study -  The Lancet
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study - The Lancet

Some patients not receiving ADHD treatment, despite overall increase | UCL  News - UCL – University College London
Some patients not receiving ADHD treatment, despite overall increase | UCL News - UCL – University College London

Inequalities in the use of secondary prevention of cardiovascular disease  by socioeconomic status: evidence from the PURE observational study - The  Lancet Global Health
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study - The Lancet Global Health

Voglibose for prevention of type 2 diabetes mellitus: a randomised,  double-blind trial in Japanese individuals with impaired glucose tolerance  - The Lancet
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance - The Lancet

Cognitive outcomes at age 3 years in children with fetal exposure to  antiseizure medications (MONEAD study) in the USA: a prospective,  observational cohort study - The Lancet Neurology
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study - The Lancet Neurology

Drug harms in the UK: a multicriteria decision analysis - The Lancet
Drug harms in the UK: a multicriteria decision analysis - The Lancet

Drug Evidence Watch for Public Health Benefit
Drug Evidence Watch for Public Health Benefit

Use of digital measurement of medication adherence and lung function to  guide the management of uncontrolled asthma (INCA Sun): a multicentre,  single-blinded, randomised clinical trial - The Lancet Respiratory Medicine
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial - The Lancet Respiratory Medicine

Implementation of a mobile health clinic framework for Hepatitis C virus  screening and treatment: a descriptive study - The Lancet Regional Health –  Americas
Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study - The Lancet Regional Health – Americas

How the structural determinants of health inequities impact access to  prescription medication for pregnant women in Australia: a narrative review  - The Lancet Regional Health – Western Pacific
How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review - The Lancet Regional Health – Western Pacific

Initiation of pharmacological therapy in Parkinson's disease: when, why,  and how - The Lancet Neurology
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology

Comparative efficacy and acceptability of 21 antidepressant drugs for the  acute treatment of adults with major depressive disorder: a systematic  review and network meta-analysis - The Lancet
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet

The Lancet Haematology Home Page
The Lancet Haematology Home Page